140 related articles for article (PubMed ID: 37093412)
1. Early and Persistent Dysphagia Relief Predicts Tumor Response in Esophageal Squamous Cell Carcinoma Patients Treated with Immunochemotherapy.
Huang S; Tang Y; Wu H; Shi Q; Tang J; Ben X; Zhang D; Xie L; Zhou H; Chen G; Wang S; Gao Z; Xie Z; Chen R; Qiao G
Ann Surg Oncol; 2023 Aug; 30(8):5171-5181. PubMed ID: 37093412
[TBL] [Abstract][Full Text] [Related]
2. Pathologic responses and surgical outcomes after neoadjuvant immunochemotherapy versus neoadjuvant chemoradiotherapy in patients with locally advanced esophageal squamous cell carcinoma.
Xu L; Wei XF; Li CJ; Yang ZY; Yu YK; Li HM; Xie HN; Yang YF; Jing WW; Wang Z; Kang XZ; Zhang RX; Qin JJ; Xue LY; Bi N; Chen XK; Li Y
Front Immunol; 2022; 13():1052542. PubMed ID: 36466925
[TBL] [Abstract][Full Text] [Related]
3. Analysis of SPARC and TUBB3 as predictors for prognosis in esophageal squamous cell carcinoma receiving nab-paclitaxel plus cisplatin neoadjuvant chemotherapy: a prospective study.
Gong L; Mao W; Chen Q; Jiang Y; Fan Y
Cancer Chemother Pharmacol; 2019 Apr; 83(4):639-647. PubMed ID: 30643929
[TBL] [Abstract][Full Text] [Related]
4. Diffusion-weighted MRI and
Xu X; Sun ZY; Wu HW; Zhang CP; Hu B; Rong L; Chen HY; Xie HY; Wang YM; Lin HP; Bai YR; Ye Q; Ma XM
Radiat Oncol; 2021 Jul; 16(1):132. PubMed ID: 34281566
[TBL] [Abstract][Full Text] [Related]
5. Placement of Polyflex stents in patients with locally advanced esophageal cancer is safe and improves dysphagia during neoadjuvant therapy.
Adler DG; Fang J; Wong R; Wills J; Hilden K
Gastrointest Endosc; 2009 Oct; 70(4):614-9. PubMed ID: 19539918
[TBL] [Abstract][Full Text] [Related]
6. Palliative stenting for relief of dysphagia in patients with inoperable esophageal cancer: impact on quality of life.
Madhusudhan C; Saluja SS; Pal S; Ahuja V; Saran P; Dash NR; Sahni P; Chattopadhyay TK
Dis Esophagus; 2009; 22(4):331-6. PubMed ID: 19473211
[TBL] [Abstract][Full Text] [Related]
7. Placement of fully covered self-expandable metal stents in patients with locally advanced esophageal cancer before neoadjuvant therapy.
Siddiqui AA; Sarkar A; Beltz S; Lewis J; Loren D; Kowalski T; Fang J; Hilden K; Adler DG
Gastrointest Endosc; 2012 Jul; 76(1):44-51. PubMed ID: 22726465
[TBL] [Abstract][Full Text] [Related]
8. Residual tumor model in esophageal squamous cell carcinoma after neoadjuvant immunochemotherapy: Frequently involves the mucosa and/or submucosa.
Gao L; Hong ZN; Wu L; Yang Y; Kang M
Front Immunol; 2022; 13():1008681. PubMed ID: 36569913
[TBL] [Abstract][Full Text] [Related]
9. Relief of dysphagia during neoadjuvant treatment for cancer of the esophagus or gastroesophageal junction.
Sunde B; Ericson J; Kumagai K; Lundell L; Tsai JA; Lindblad M; Rouvelas I; Friesland S; Wang N; Nilsson M
Dis Esophagus; 2016 Jul; 29(5):442-7. PubMed ID: 25809837
[TBL] [Abstract][Full Text] [Related]
10. The role of
Wang X; Yang W; Zhou Q; Luo H; Chen W; Yeung SJ; Zhang S; Gan Y; Zeng B; Liu Z; Feng S; Zhang X; Cheng C
Eur J Nucl Med Mol Imaging; 2022 Oct; 49(12):4241-4251. PubMed ID: 35732974
[TBL] [Abstract][Full Text] [Related]
11. Multi-omics analysis uncovers tumor ecosystem dynamics during neoadjuvant toripalimab plus nab-paclitaxel and S-1 for esophageal squamous cell carcinoma: a single-center, open-label, single-arm phase 2 trial.
Zhang G; Yuan J; Pan C; Xu Q; Cui X; Zhang J; Liu M; Song Z; Wu L; Wu D; Luo H; Hu Y; Jiao S; Yang B
EBioMedicine; 2023 Apr; 90():104515. PubMed ID: 36921563
[TBL] [Abstract][Full Text] [Related]
12. Development of a nomogram for the prediction of pathological complete response after neoadjuvant chemoradiotherapy in patients with esophageal squamous cell carcinoma.
Chao YK; Chang HK; Tseng CK; Liu YH; Wen YW
Dis Esophagus; 2017 Feb; 30(2):1-8. PubMed ID: 27868287
[TBL] [Abstract][Full Text] [Related]
13. Effects of neoadjuvant chemoradiotherapy vs chemotherapy alone on the relief of dysphagia in esophageal cancer patients: secondary endpoint analysis in a randomized trial.
Sunde B; Johnsen G; Jacobsen AB; Glenjen NI; Friesland S; Lindblad M; Rouvelas I; Wang N; Lundell L; Lagergren P; Nilsson M
Dis Esophagus; 2019 Feb; 32(2):. PubMed ID: 30084992
[TBL] [Abstract][Full Text] [Related]
14. Is a change in patient-reported dysphagia after induction chemotherapy in locally advanced esophageal cancer a predictive factor for pathological response to neoadjuvant chemoradiation?
Ribi K; Koeberle D; Schuller JC; Honegger H; Roth A; Hess V; Moosmann P; von Moos R; Borner M; Lombriser N; Pestalozzi B; Ruhstaller T
Support Care Cancer; 2009 Aug; 17(8):1109-16. PubMed ID: 19198893
[TBL] [Abstract][Full Text] [Related]
15. Pretreatment absolute lymphocyte count is an independent predictor for survival outcomes for esophageal squamous cell carcinoma patients treated with neoadjuvant chemoradiotherapy and pembrolizumab: An analysis from a prospective cohort.
Qi WX; Wang X; Li C; Li S; Li H; Xu F; Chen J; Zhao S; Li H
Thorac Cancer; 2023 Jun; 14(17):1556-1566. PubMed ID: 37089116
[TBL] [Abstract][Full Text] [Related]
16. Predictive value of systemic immune-inflammation index for pathological complete response in patients receiving neoadjuvant immunochemotherapy for locally advanced esophageal cancer.
Han W; Weng K; Zhang P; Hong Z
Front Surg; 2022; 9():1091601. PubMed ID: 36684142
[TBL] [Abstract][Full Text] [Related]
17. Health-related quality of life and treatment modality among esophageal squamous cell carcinoma survivors: A prospective study using time to deterioration model analysis.
Liu S; Lin Z; Lin J; Chen H; Xie Q; Rao W; Chen Y; Yu K; Hu Z
J Surg Oncol; 2021 Jan; 123(1):156-163. PubMed ID: 33126290
[TBL] [Abstract][Full Text] [Related]
18. The usefulness of pretreatment controlling nutritional status score for predicting recurrence in patients with esophageal squamous cell carcinoma undergoing neoadjuvant immunochemotherapy: A real-world study.
Feng J; Wang L; Yang X; Chen Q; Cheng X
Front Immunol; 2022; 13():1015365. PubMed ID: 36505443
[TBL] [Abstract][Full Text] [Related]
19.
Wang S; Di S; Lu J; Xie S; Yu Z; Liang Y; Gong T
Thorac Cancer; 2023 Aug; 14(24):2338-2349. PubMed ID: 37424279
[TBL] [Abstract][Full Text] [Related]
20. Self-Expanding Metal Stents Improve Swallowing and Maintain Nutrition During Neoadjuvant Therapy for Esophageal Cancer.
Smith ZL; Gonzaga JE; Haasler GB; Gore EM; Dua KS
Dig Dis Sci; 2017 Jun; 62(6):1647-1656. PubMed ID: 28391413
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
